会員登録
ログイン
【2191】テラ
〔上場廃止〕
ー(上場廃止)免疫細胞医療。
業績予想修正履歴
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022.12 | 2022/05/13 | 当初予 | 27 | - | - | - | -640 | - | - | - | -638 | - | - | - | -639 | - | - | - |
| 2021.12 | 2022/02/14 | 実 | 106 | - | - | - | -794 | - | - | - | -792 | - | - | - | -948 | - | - | - |
| 2020.12 | 2021/02/15 | 実 | 76 | - | - | - | -1,089 | - | - | - | -1,099 | - | - | - | -1,067 | - | - | - |
| 2019.12 | 2020/02/13 | 実 | 202 | → | 0.0% | -63.2% | -716 | ↓ | -0.1% | +19.1% | -773 | → | 0.0% | +19.2% | -1,026 | ↓ | -0.1% | -6.9% |
| 2019.12 | 2020/02/07 | 修正予 | 202 | ↓ | -15.5% | -63.2% | -715 | ↓ | -1.0% | +19.2% | -773 | → | 0.0% | +19.2% | -1,025 | ↓ | -0.4% | -6.8% |
| 2019.12 | 2019/11/11 | Q3予 | 239 | → | 0.0% | -56.5% | -708 | → | 0.0% | +20.0% | -773 | → | 0.0% | +19.2% | -1,021 | → | 0.0% | -6.4% |
| 2019.12 | 2019/08/13 | Q2予 | 239 | ↓ | -56.5% | -56.5% | -708 | ↑ | +20.0% | +20.0% | -773 | ↑ | +19.2% | +19.2% | -1,021 | ↓ | -6.4% | -6.4% |
| 2019.12 | 2019/05/13 | Q1予 | 549 | → | 0.0% | 0.0% | -885 | → | 0.0% | 0.0% | -957 | → | 0.0% | 0.0% | -960 | → | 0.0% | 0.0% |
| 2019.12 | 2019/02/15 | 当初予 | 549 | - | - | - | -885 | - | - | - | -957 | - | - | - | -960 | - | - | - |
| 2018.12 | 2019/02/15 | 実 | 516 | ↑ | +1.2% | +1.2% | -685 | ↑ | +35.4% | +35.4% | -755 | ↑ | +32.3% | +32.3% | -929 | ↑ | +17.1% | +17.1% |
| 2018.12 | 2018/11/14 | Q3予 | 510 | → | 0.0% | 0.0% | -1,060 | → | 0.0% | 0.0% | -1,115 | → | 0.0% | 0.0% | -1,120 | → | 0.0% | 0.0% |
| 2018.12 | 2018/10/15 | Q2予 | 510 | → | 0.0% | 0.0% | -1,060 | → | 0.0% | 0.0% | -1,115 | → | 0.0% | 0.0% | -1,120 | → | 0.0% | 0.0% |
| 2018.12 | 2018/05/11 | Q1予 | 510 | → | 0.0% | 0.0% | - | - | - | - | -1,115 | → | 0.0% | 0.0% | -1,120 | → | 0.0% | 0.0% |
| 2018.12 | 2018/02/13 | 当初予 | 510 | - | - | - | -1,060 | - | - | - | -1,115 | - | - | - | -1,120 | - | - | - |
| 2017.12 | 2018/02/13 | 実 | 957 | ↑ | +0.7% | -44.4% | -245 | ↓ | -22.5% | -345.0% | -261 | ↓ | -13.5% | -426.3% | -643 | ↓ | -7.2% | -83.7% |
| 2017.12 | 2017/11/10 | Q3予 | 950 | → | 0.0% | -44.8% | -200 | → | 0.0% | -300.0% | -230 | → | 0.0% | -387.5% | -600 | → | 0.0% | -71.4% |
| 2017.12 | 2017/11/09 | 修正予 | 950 | ↓ | -30.7% | -44.8% | -200 | ↓ | -66.7% | -300.0% | -230 | ↓ | -53.3% | -387.5% | -600 | ↓ | -66.7% | -71.4% |
| 2017.12 | 2017/08/10 | Q2予 | 1,370 | ↓ | -20.3% | -20.3% | -120 | ↓ | -220.0% | -220.0% | -150 | ↓ | -287.5% | -287.5% | -360 | ↓ | -2.9% | -2.9% |
| 2017.12 | 2017/05/12 | Q1予 | 1,720 | → | 0.0% | 0.0% | 100 | → | 0.0% | 0.0% | 80 | → | 0.0% | 0.0% | -350 | → | 0.0% | 0.0% |
| 2017.12 | 2017/02/14 | 当初予 | 1,720 | - | - | - | 100 | - | - | - | 80 | - | - | - | -350 | - | - | - |
| 2016.12 | 2017/02/14 | 実 | 1,801 | ↓ | -2.6% | -12.2% | -621 | ↓ | -38.0% | -96.5% | -667 | ↓ | -41.9% | -103.4% | -918 | ↓ | -66.9% | -163.0% |
| 2016.12 | 2016/11/11 | Q3予 | 1,850 | → | 0.0% | -9.8% | -450 | → | 0.0% | -42.4% | -470 | → | 0.0% | -43.3% | -550 | → | 0.0% | -57.6% |
| 2016.12 | 2016/08/12 | Q2予 | 1,850 | ↓ | -9.8% | -9.8% | -450 | ↓ | -42.4% | -42.4% | -470 | ↓ | -43.3% | -43.3% | -550 | ↓ | -57.6% | -57.6% |
| 2016.12 | 2016/05/13 | Q1予 | 2,052 | → | 0.0% | 0.0% | -316 | → | 0.0% | 0.0% | -328 | → | 0.0% | 0.0% | -349 | → | 0.0% | 0.0% |
| 2016.12 | 2016/02/09 | 当初予 | 2,052 | - | - | - | -316 | - | - | - | -328 | - | - | - | -349 | - | - | - |
| 2015.12 | 2016/02/09 | 実 | 1,909 | ↓ | -1.9% | -14.0% | -601 | ↑ | +11.7% | -64.7% | -623 | ↑ | +12.4% | -76.5% | -990 | ↓ | -36.4% | -159.8% |
| 2015.12 | 2015/11/10 | Q3予 | 1,945 | → | 0.0% | -12.4% | -681 | → | 0.0% | -86.6% | -711 | → | 0.0% | -101.4% | -726 | → | 0.0% | -90.6% |
| 2015.12 | 2015/08/07 | Q2予 | 1,945 | ↓ | -12.4% | -12.4% | -681 | ↓ | -86.6% | -86.6% | -711 | ↓ | -101.4% | -101.4% | -726 | ↓ | -90.6% | -90.6% |
| 2015.12 | 2015/05/01 | Q1予 | 2,221 | → | 0.0% | 0.0% | -365 | → | 0.0% | 0.0% | -353 | → | 0.0% | 0.0% | -381 | → | 0.0% | 0.0% |
| 2015.12 | 2015/02/13 | FY予 | 2,221 | → | 0.0% | 0.0% | -365 | → | 0.0% | 0.0% | -353 | → | 0.0% | 0.0% | -381 | → | 0.0% | 0.0% |
| 2015.12 | 2015/02/06 | 当初予 | 2,221 | - | - | - | -365 | - | - | - | -353 | - | - | - | -381 | - | - | - |
| 2014.12 | 2015/02/13 | 実 | 1,865 | → | 0.0% | -10.8% | -293 | → | 0.0% | -117.0% | -330 | → | 0.0% | -111.5% | -402 | → | 0.0% | -161.0% |
| 2014.12 | 2015/02/06 | 実 | 1,865 | ↓ | -8.6% | -10.8% | -293 | ↑ | +7.3% | -117.0% | -330 | ↑ | +6.0% | -111.5% | -402 | ↓ | -24.1% | -161.0% |
| 2014.12 | 2014/11/07 | Q3予 | 2,040 | → | 0.0% | -2.4% | -316 | → | 0.0% | -134.1% | -351 | → | 0.0% | -125.0% | -324 | → | 0.0% | -110.4% |
| 2014.12 | 2014/08/05 | Q2予 | 2,040 | → | 0.0% | -2.4% | -316 | → | 0.0% | -134.1% | -351 | → | 0.0% | -125.0% | -324 | → | 0.0% | -110.4% |
| 2014.12 | 2014/08/01 | 修正予 | 2,040 | ↓ | -2.4% | -2.4% | -316 | ↓ | -134.1% | -134.1% | -351 | ↓ | -125.0% | -125.0% | -324 | ↓ | -110.4% | -110.4% |
| 2014.12 | 2014/05/02 | Q1予 | 2,090 | → | 0.0% | 0.0% | -135 | → | 0.0% | 0.0% | -156 | → | 0.0% | 0.0% | -154 | → | 0.0% | 0.0% |
| 2014.12 | 2014/02/07 | 当初予 | 2,090 | - | - | - | -135 | - | - | - | -156 | - | - | - | -154 | - | - | - |
| 2013.12 | 2014/02/07 | 実 | 1,539 | → | 0.0% | 0.0% | 23 | → | 0.0% | 0.0% | -24 | → | 0.0% | 0.0% | -58 | → | 0.0% | 0.0% |
| 2013.12 | 2014/01/31 | 当初予 | 1,539 | - | - | - | 23 | - | - | - | -24 | - | - | - | -58 | - | - | - |
